S&P・Nasdaq 本質的価値 お問い合わせ

Intelligent Bio Solutions Inc. INBS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-36.70 および 売上高 $0.00B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-6.38 vs 予想 $-36.70 (上回る +82.6%). 2025: 実績 $-20.00 vs 予想 $-12.50 (下回る -60%). アナリスト精度: 0%.

EPS予測 — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$6.38 vs Est –$36.70 ▲ 475.2% off
2025 Actual –$20.00 vs Est –$12.50 ▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

売上高予測 — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.004B ▼ 35.0% off
2025 Actual $0.003B vs Est $0.012B ▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る